About Michael Allio
Form D filings for St. James Therapeutics in 2023 list Michael Allio as executive officer and director.
Michael Allio first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Allio in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Allio works with at each company, as listed on that company's latest Form D.
St. James Therapeutics Inc. · Form D, Nov 14, 2023
MA
Mark Allio
Executive officer and director
MA
Michele Allio
Director